Editas Medicine Inc (EDIT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Editas Medicine Inc   (NASDAQ: EDIT)


Editas Medicine Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Editas Medicine Inc's ROI in the second quarter of 2026?
Editas Medicine Inc recorded a cumulative net loss of $-74 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -52.94%.

Within the Healthcare sector 492 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3767 to 3962.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -34.63 % -47.63 % -48.88 % -46.24 % -45.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 169 110 140 140 145
Return On Investment (TTM) -52.94 % -81.54 % -104.03 % -108.09 % -110.84 %
EDIT's Overall Ranking # 3962 # 3767 # 2754 # 0 # 3323
Seq. Investment Change TTM 4.54 % -13.16 % -16.78 % -13.48 % -16.25 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -74 -109 -160 -200 -237

EDIT Company Profile >> Back to EDIT Roi Comparisons >> See Annual EDIT Return On Investment



Return On Investment EDIT's Ranking
Within: No.
Industry # 75
Sector # 493
Overall # 3962

Return On Investment Statistics
High Average Low
-17.71 %
-45.04 %
-107.95 %
(Sep 30 2020)   (Jun 30 2025)







Financial Statements
Editas Medicine Inc's II. Quarter Investments $ 169 Millions EDIT's Balance sheet
Editas Medicine Inc's II. Quarter Income $ -18 Millions Quarterly EDIT's Income Statement
EDIT's Income by Division See EDIT's Income by Division


EDIT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 140 264 436 454 631
Y / Y Investment Growth -46.93 % -39.36 % -4.02 % -27.97 % 22.59 %
Net Income in Millions -160 -237 -153 -220 -193
Y / Y Net Income Growth - - - - -
Annual Return On Investment -114.09 % -89.68 % -35.15 % -48.53 % -30.53 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EDIT's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EDIT's Competitors
Subscribers only: Roi for Editas Medicine Inc's Suppliers
Subscribers only: Return On Investment for EDIT's Customers

Other Ratios
EDIT's Roa EDIT's Inventory Turnover Ratio EDIT's Growth Rates EDIT's Dividend Statistics
EDIT's Profitability Ratios EDIT's Asset Turnover Ratio EDIT's Dividend Growth
EDIT's Roe EDIT's Valuation Ratios EDIT's Financial Strength Ratios EDIT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-08T17:29:50+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.